Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Cepheid Inc (CPHD)

Cepheid Inc (CPHD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,880,330
  • Shares Outstanding, K 72,890
  • Annual Sales, $ 538,580 K
  • Annual Income, $ -48,530 K
  • 60-Month Beta 0.67
  • Price/Sales 7.20
  • Price/Cash Flow N/A
  • Price/Book 10.19
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.54
  • Most Recent Earnings 0.05 on 07/28/16
  • Next Earnings Date 11/08/16
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/16
See More
  • Average Estimate -0.11
  • Number of Estimates 6
  • High Estimate -0.09
  • Low Estimate -0.13
  • Prior Year -0.27
  • Growth Rate Est. (year over year) +59.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
52.52 +0.82%
on 10/28/16
53.00 -0.09%
on 11/04/16
+0.29 (+0.55%)
since 10/04/16
3-Month
34.00 +55.74%
on 09/02/16
53.91 -1.78%
on 09/19/16
+16.30 (+44.47%)
since 08/04/16
52-Week
25.09 +111.04%
on 05/06/16
53.91 -1.78%
on 09/19/16
+17.07 (+47.58%)
since 11/04/15

Most Recent Stories

More News
Hong Kong Automated Microbiology Market for over 100 Tests: Some of the Companies Included are Abbott, Cepheid, Hologic & Roche - ResearchAndMarkets.com

The "Hong Kong Automated Microbiology Market for over 100 Tests" report has been added to ResearchAndMarkets.com's offering.

CPHD : 52.95 (unch)
HOLX : 52.20 (+0.19%)
Cepheid Receives FDA Clearance for Xpert® BCR-ABL Ultra Test

Cepheid today announced that it has received clearance from the U.S. Food and Drug Administration for Xpert BCR-ABL Ultra for monitoring disease burden in patients with Chronic Myeloid Leukemia (CML)....

CPHD : 52.95 (unch)
CORRECTING and REPLACING SpeeDx and Cepheid Announce Test Partnership

First sentence, seventh paragraph of release dated April 16, 2019 should read: "Currently, there is no FDA-cleared molecular diagnostic test for the combined detection of M. genitalium and...

CPHD : 52.95 (unch)
SpeeDx and Cepheid Announce Test Partnership

SpeeDx Pty, Ltd. announced an agreement with Cepheid to manufacture their market-leading ResistancePlus(R) tests for use on the GeneXpert System. The first test in Cepheid's FleXible...

CPHD : 52.95 (unch)
Cepheid Announces FleXible Cartridge Program

Cepheid today announced its FleXible Cartridge program to accelerate menu expansion in Europe and China through partnerships with selected Trusted Reagent Manufacturers (TRMs). Through this program, GeneXpert®...

CPHD : 52.95 (unch)
Tuberculosis Diagnostics - Worldwide Markets, 2024: Abbott; Becton, Dickinson and Company; bioMerieux; Cepheid; and F. Hoffmann-La Roche are Dominating

The "Tuberculosis Diagnostics Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering.

CPHD : 52.95 (unch)
Trade CPHD with:

Business Summary

Cepheid, Inc. develops, manufactures and markets microfluidic systems that integrate, automate and accelerate biological testing. Their systems are miniaturized instruments that analyze complex biological samples in a disposable cartridge by combining molecular biology with microfluidic technology that...

See More

Key Turning Points

2nd Resistance Point 53.02
1st Resistance Point 52.98
Last Price 52.95
1st Support Level 52.93
2nd Support Level 52.92

See More

52-Week High 53.91
Last Price 52.95
Fibonacci 61.8% 42.90
Fibonacci 50% 39.50
Fibonacci 38.2% 36.10
52-Week Low 25.09

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar